Investment Bank Downgrades Luminex, Qiagen Stocks
January 14, 2013
Investment Bank Downgrades Luminex, Qiagen Stocks
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Focus: Cepheid Xpert CT/NG; Qiagen Therascreen EGFR; Luminex xTag GPP; Hologic Aptima Trichomonas
January 17, 2013 / PCR Insider - FDA Clears Luminex's Gastrointestinal Pathogen Assay
January 15, 2013 / GenomeWeb Daily News - Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News - Luminex Goes to Direct Sales Channel for MDx
December 12, 2012 / GenomeWeb Daily News - Qiagen, Bayer Partner on Cancer Companion Dx
October 25, 2012 / GenomeWeb Daily News